Cargando…

Serum 3-Hydroxybutyrate in Patients with Psychogenic Somatoform Symptoms May Be a Predictor of the Effectiveness of Sertraline and Venlafaxine

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs) are often used to treat outpatients with psychogenic somatoform symptoms but prove ineffective in some cases. The metabolite 3-hydroxybutyrate (3HB) is currently attracting attention a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saito, Norihiro, Itoga, Masamichi, Minakawa, Satoko, Kayaba, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121269/ https://www.ncbi.nlm.nih.gov/pubmed/34007205 http://dx.doi.org/10.2147/IJGM.S300517

Ejemplares similares

Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan
por: Saito, Norihiro, et al.
Publicado: (2022)

Rethinking the Psychogenic Model of Complex Regional Pain Syndrome: Somatoform Disorders and Complex Regional Pain Syndrome
por: Hill, Renee J., et al.
Publicado: (2012)

Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study
por: Sonne, Charlotte, et al.
Publicado: (2016)

Treatment of traumatized refugees with Sertraline versus Venlafaxine in combination with psychotherapy – study protocol for a randomized clinical trial
por: Sonne, Charlotte, et al.
Publicado: (2013)

Venlafaxine-induced psychotic symptoms
por: Safeekh, A. T., et al.
Publicado: (2009)

Evaluating effectiveness of infection control efforts in hospitals using information in microbiological laboratory databases
por: Saito, Norihiro, et al.
Publicado: (2017)

Somatic symptoms with psychogenic or psychiatric background: Characteristics and pitfalls
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Recent developments on psychological factors in medically unexplained symptoms and somatoform disorders
por: Mewes, Ricarda
Publicado: (2022)

LIFE EVENTS AND SOMATOFORM DISORDERS
por: Chandrashekhar, C.R., et al.
Publicado: (1997)

Prognosis and Outcome Predictors in Psychogenic Nonepileptic Seizures
por: Durrant, Joseph, et al.
Publicado: (2011)

Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine
por: Koga, M, et al.
Publicado: (2009)

Altered Interoceptive Awareness in High Habitual Symptom Reporters and Patients With Somatoform Disorders
por: Flasinski, Tabea, et al.
Publicado: (2020)

Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine
por: Luong, Thu-Lan T., et al.
Publicado: (2022)

Pain drawings in somatoform-functional pain
por: Egloff, Niklaus, et al.
Publicado: (2012)

Headaches as Somatoform Disorders in Children and Adolescents
por: Emich-Widera, Ewa, et al.
Publicado: (2012)

Body image in patients with somatoform disorder
por: Scheffers, M., et al.
Publicado: (2018)

Study of Determinants of Somatoform Disorders in Children
por: Shanker, Ganesh, et al.
Publicado: (2023)

Psychogenic fever, functional fever, or psychogenic hyperthermia?
por: Olivier, Berend
Publicado: (2015)

An Evaluation of Psychogenic Predictors of Non-Organic Erectile Dysfunction
por: Topak, Osman Zulkif, et al.
Publicado: (2023)

Diagnosis of somatoform disorders in primary care: diagnostic agreement, predictors, and comaprisons with depression and anxiety
por: Piontek, Katharina, et al.
Publicado: (2018)

Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
por: Gahr, Maximilian, et al.
Publicado: (2020)

Apathy symptoms induced by low‐dose venlafaxine: Two cases
por: Sato, Shinji, et al.
Publicado: (2020)

Psychogenic Pseudo-responses in an Electrical Cortical Stimulation
por: TAMADA, Tomoaki, et al.
Publicado: (2019)

Mass Psychogenic Illness: Demography and Symptom Profile of an Episode
por: Tarafder, Binoy Krishna, et al.
Publicado: (2016)

Six-month trial of Yoga Nidra in menstrual disorder patients: Effects on somatoform symptoms
por: Rani, Khushbu, et al.
Publicado: (2011)

Somatoform Dissociative Symptoms Have No Impact on the Outcome of Trauma-Focused Treatment for Severe PTSD
por: Zoet, Harmen A., et al.
Publicado: (2021)

Somatoform Symptoms among Frontline Health-Care Providers during the COVID-19 Pandemic
por: Jacob, Jaison, et al.
Publicado: (2021)

Serum 3-Hydroxybutyrate is Expected to Serve as One of the Supportive Diagnostic Markers of Persistent Idiopathic Dentoalveolar Pain (PDAP)
por: Tamaki, Katsuya, et al.
Publicado: (2023)

VENLAFAXINE-INDUCED MANIA
por: Jagadheesan, K., et al.
Publicado: (2001)

Venlafaxine besylate monohydrate
por: Corvalan, Carolina H., et al.
Publicado: (2013)

Kleptomania Induced by Venlafaxine
por: Sakurada, Kumi, et al.
Publicado: (2021)

Venlafaxine-induced hypoglycemia
por: Kobylianskii, Jane, et al.
Publicado: (2021)

Sepsis caused by Listeria monocytogenes during chemotherapy for small cell carcinoma of the thymus
por: Itoga, Masamichi, et al.
Publicado: (2015)

Prevalence of somatoform pain complaints in the German population
por: Hessel, Aike, et al.
Publicado: (2005)

Current debates over nosology of somatoform disorders
por: Jana, Amlan K., et al.
Publicado: (2012)

Clinical Practice Guideline: Psychotherapies for Somatoform Disorders
por: Agarwal, Vivek, et al.
Publicado: (2020)

Somatoform disorders. Models of personification oriented therapy
por: Kudinova, O., et al.
Publicado: (2022)

Psychogenic Polydipsia
por: Kohli, Ajay, et al.
Publicado: (2011)

Psychogenic sneezing
por: Mangot, Ajish G., et al.
Publicado: (2015)

Psychogenic Pain
por: Gordon, R. G.
Publicado: (1948)

Cannot write session to /tmp/vufind_sessions/sess_ujnbk47k9ilti8a83ki9mgpo9j